Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p

CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p

(2018) Jun Li et al.   BIOMEDICINE & PHARMACOTHERAPY

miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma

(2017) Zijun Yin et al.   GENE

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2

(2017) Nan Ding et al.   OncoTargets and Therapy

Targeting MicroRNAs in Cancer Gene Therapy

(2017) Weidan Ji et al.   Genes

Luteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C–C motif) ligand 2 expression in tumor-associated macrophage

(2016) Hee-Jin Choi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females

(2016) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK/ERK signaling pathway

(2016) Guanmin Meng et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway

(2016) Huimin Lu et al.   DIABETOLOGIA

miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer

(2016) Hui Shi et al.   PATHOLOGY RESEARCH AND PRACTICE

Effect and mechanism of miR-34a on proliferation, apoptosis and invasion of laryngeal carcinoma cells

(2016) Ju-Xiang Wang et al.   Asian Pacific Journal of Tropical Medicine

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

(2016) Kun Han et al.   OncoTargets and Therapy

5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis

(2015) Zheng Hu et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes

(2015) LIN ZHU et al.   Molecular Medicine Reports

A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells

(2015) Hongbo Wang et al.   NEOPLASIA

Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival

(2014) Omer Araz et al.   Clinical Respiratory Journal

Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells

(2014) Samik Chakraborty et al.   FEBS LETTERS

Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes

(2014) Jingcheng Yang et al.   LUNG CANCER

miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer

(2014) J Gao et al.   ONCOGENE

Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2

(2014) XIANHONG OU et al.   ONCOLOGY REPORTS

Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells

(2014) Hao Wu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis

(2013) Matthew Brentnall et al.   BMC CELL BIOLOGY

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame

(2012) Pooja Mandke et al.   PLoS One

Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells

(2011) Xueting Cai et al.   TOXICOLOGY IN VITRO

Blinded by the Light: The Growing Complexity of p53

(2009) Karen H. Vousden et al.   CELL

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

(2008) Yong Lin et al.   CURRENT CANCER DRUG TARGETS